AstraZeneca-Amgen drug fails main goal of late-stage asthma study

AstraZeneca and Amgen said on Tuesday their experimental asthma drug tezepelumab failed to meet the main goal of reducing patients’ dependence on steroids, while keeping the respiratory condition in check in a late-stage trial.

from bdnews24.com - Home https://ift.tt/3ayx66b